This change is happening because there’s another covered medication that’s safe and effective for your condition and may cost ...

Hims & Hers thrives with telehealth growth, strong subscriber base, and expanding products, despite challenges like ...

You've heard about the likes of Ozempic, Wegovy and Mounjaro, jabs which a growing number of people are taking in an attempt ...

Innovation in obesity treatments, Alzheimer's detection and medical-device applications is setting the stage for a number of ...

The research and development of new pharmaceuticals is increasingly an international affair, something that recent discussion ...

CVS Caremark will stop covering Eli Lilly's Zepbound, a weight loss drug, due to insurance company changes. Patients are outraged and concerned.

GLP-1 drugs currently being tested in China target complications associated with obesity such as heart disease, fatty liver ...

Chinese drugmaker Innogen expects to complete a late-stage clinical trial of its experimental weight-loss drug candidate next year, its CEO said on Tuesday, the latest Chinese company to join the race ...

Another major insurance change coming next year will affect another large swath of Dushay’s patients: In January, BCBS ...

Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer.

The UK's medicines regulator has launched a study to investigate the impact of these drugs following reports of people dying ...